Results: Seventy-six women were allocated to the intervention (n = 40) or waitlist (n = 36). A significant interaction was found on the instrumental activities of daily living measure of selfreported prospective memory whereby the intervention group reported a greater reduction in prospective memory failures than the waitlist group. Interaction trends were noted on perceived cognitive impairments (P = .089) and executive functioning (P = .074). No significant interactions were observed on other measures of objective cognitive functioning or psychosocial variables.
rehabilitation therapy (CRT) is the process of reattaining cognitive skills that have been lost or altered because of injury whereby the goal of treatment is to improve functioning on everyday tasks. 16 Cognitive rehabilitation therapy incorporates psychoeducation, skills training, strategy training, and functional activity training to apply the strategies in everyday life.
Web-based interventions in this area have been scarce. There are no published studies evaluating online CRT in cancer survivors and only 3 online CT interventions. Kesler and colleagues conducted an RCT with 41 breast cancer survivors, 21 of whom received Web-based CT 4 times per week for 12 weeks. Improved objective executive functioning, processing speed, and verbal fluency and improved subjective executive functioning skills were reported in the treatment group postintervention. 14 In another study, Damholdt and colleagues recruited 157 breast cancer survivors and randomly allocated 94 to Web-based CT with email support (eCogT) compared with waitlist. They reported no significant group differences on primary or secondary outcome measures of working memory and perceived cognitive functioning but found significant improvements for verbal learning and another working memory test in the eCogT group at follow-up. 17 Most recently, Bray and colleagues conducted an RCT with 242 adult cancer survivors, 121 of whom were assigned to CT with a recommended four 40-minute sessions per week for 15 weeks. They reported significantly less perceived cognitive impairment (PCI) and reduced psychological distress and fatigue at postintervention and follow-up in the intervention group. 18 The objective of our study was to evaluate the efficacy of a Web-based CRT program called eReCog. The program was adapted from the face-to-face responding to cognitive concerns (ReCog) intervention and piloted with small samples of cancer survivors and community-dwelling adults with beneficial results. 19 The main hypothesis was that participants in eReCog would improve more on self-reported cognition compared with a waitlist control group at postintervention and follow-up. Objective cognition; psychosocial variables of distress, QoL, illness perception, and fatigue; and program satisfaction were assessed as secondary outcomes relevant to this population. 12, 20, 21 2 | METHODS
| Intervention
Responding to cognitive concerns was developed as a manualised face-to-face 4-session group intervention to address cognitive dysfunction in cancer survivors. 12, 21, 22 This intervention was adapted into a Web-based version (eReCog). Its development process and piloting trial are described elsewhere. 19 Based on the principles of cognitive behavioural therapy, the program contains 4 modules, each including psychoeducation, relaxation, strategy training, discussion questions that allow viewing of others' anonymised responses, and homework. 23 Modules take approximately 30 to 60 minutes, and participants are expected to complete 1 module per week over 4 weeks. Module topics are (1) ageing, health, cancer, and cognitive function, (2) memory, (3) attention, and (4) fatigue, emotions, and cognition.
| Participants
Sixty-five participants were sought, based on a priori power analysis demonstrating 80% power for detecting small-to-moderate interaction effects 12, 21 at α = .05, with an additional 20% (11 participants) added to allow for attrition. Seventy-six participants were eligible and randomly allocated to intervention (n = 40) or waitlist (n = 36). Eligibility criteria were diagnosed with adult-onset cancer excluding central nervous system tumours, aged 18+ years, reported cognitive complaints with memory or concentration, completed primary treatment at least 6 months prior (excluding hormonal treatment, which could be ongoing), were disease-free at the time of enrolment, and able to read and write English fluently. Exclusion criteria were currently undergoing primary treatment, history of traumatic brain injury or neurological disorder, poorly managed anxiety or depression, or insufficient English skills.
| Procedure
The study was approved by Griffith University's ethics committee and preregistered at http://www.anzctr.org.au (ACTRN12615000878572).
Individuals were recruited through emails sent to Breast Cancer Net- Eligible participants were informed of group allocation and were requested to confirm consent via email. Upon receiving written consent, participants were emailed links to complete the first assessment (baseline). Intervention participants then completed eReCog and control participants underwent a 4-week waiting period. Participants were reassessed after the intervention or wait period (posttreatment) and completed a follow-up assessment after a further 3 months. After the 3-month follow-up assessment, participants in the waitlist group could choose to complete the intervention.
| Email delivery and support
Links to WebNeuro assessment, 25 This 37-item measure assesses memory, concentration, language, and thinking abilities in cancer patients. 26 It contains 4 subscales: PCI, perceived cognitive abilities (PCA), comments from others (OTH), and impact on quality of life (QOL). As recommended, PCI was used as the primary measure of subjective cognitive functioning. 26 
Brief Assessment of Prospective Memory
This 16-item self-report measure was designed to evaluate frequency of prospective memory failures in individuals with brain injury. 27 Prospective memory is the ability to remember to complete intended actions in the future despite everyday distractions. 28 Eight items com- 
| Objective cognitive functioning
The online test battery WebNeuro comprises 11 computerised tasks assessing 7 cognitive domains: verbal memory, working memory, attention, response speed, information processing efficiency, executive functioning, and impulsivity. 25 
| Psychosocial variables
Kessler Psychological Distress Scale
This 10-item self-report measure assesses levels of anxiety and depressive symptoms in the past 4 weeks. 33 Brief Illness Perception Questionnaire
Perceived threat of illness was assessed with an 8-item questionnaire.
The term "illness" can be substituted with other relevant terms. 34 Here,
"illness" was substituted with "cognitive difficulties," as previously examined with cancer survivors. 12 
Fatigue
Symptoms of fatigue were assessed with the 3-item EORTC-QLQ-C30 fatigue symptom scale. 24 
| Program satisfaction
Satisfaction was measured by intervention participants' ratings of (1) satisfaction with the program, (2) change in cognitive functioning,
and (3) likelihood of recommending the program to others on a 5-point Likert scale. 12, 21 They provided an overall program rating from 1 (very poor) to 10 (excellent) and were asked to comment on aspects of the program found most enjoyable, least enjoyable, or otherwise noteworthy.
| Statistical analyses
The Table 1 .
| Subjective cognitive functioning
Descriptive statistics for self-report measures are presented in Table 2 .
A significant interaction occurred on the prospective memory IADL subscale, F 2,126 = 3.80, P = .025, η 2 = .045, because the intervention group reported a reduction in prospective memory failures at posttreatment, F 1,31 = 9.11, P = .005, and 3-month follow-up, F 1,31 = 33.00, P < .001, and the waitlist group a reduction at 3-month follow-up only, F 1,32 = 5.99, P = .020.
An interaction trend was noted on the PCI, F 2,109 = 2.57, P = .089.
Mean improvements from baseline to follow-up were 8.9 for intervention and 5.6 for waitlist participants, compared with an estimated minimally important difference of 6.5 for this measure. 
| Objective cognitive functioning
No significant Group × Time interactions were found on domains of neuropsychological testing. A trend towards an interaction was noted for executive functioning, F 2,112 = 2.83, P = .063. Within-group effects and effect sizes for each cognitive domain are shown in Table 3 . 
| Psychosocial variables
No interactions were found on psychosocial variables (Table 2) .
Intervention participants reported reduced fatigue at posttreatment, No significant effects were found on measures of distress or illness perceptions.
| Participant satisfaction
Among intervention participants, 94% were "satisfied" or "very satisfied" and 6% were "neither satisfied nor dissatisfied"; 84% were "likely" or "very likely" to recommend the program; 68% reported that their cognitive functioning had improved "a little" or "a lot," whereas 32% reported "no change." The mean rating of the program was 7.7/10 ranging from 5 (average) to 10 (excellent).
| DISCUSSION
This RCT aimed to evaluate the efficacy of eReCog in adult cancer survivors. We hypothesised that intervention participants would report improved subjective cognition compared with waitlist participants, a hypothesis that was partially supported. A significant Group × Time interaction and 2 trends towards interactions were found, all representing greater improvements in the intervention than the waitlist group.
The primary outcome measure PCI demonstrated a trend towards an interaction (P = .089). The intervention group surpassed the minimally important difference of 6.5 points on this measure from baseline to 3-month follow-up, indicating clinically relevant reductions in their perceived cognitive impairment, whereas the waitlist group did not. Participants in this study reported fewer problems with their PCI at baseline than previous cancer cognitive rehabilitation studies. 12, 18, 21, 36, 37 Having more stringent inclusion criteria (eg, reporting "quite a bit" of difficulty with memory or concentration) might have resulted in a more impaired sample allowing for greater improvement. Notwithstanding, baseline PCI scores in this study were still lower than noncancer comparison groups, and their follow-up scores, although improved, remained below baseline scores for healthy individuals. 12, 19 Improved PCI on the FACT-Cog-3 was observed in both groups, similar to previous research with cancer survivors. King and Green's RCT using the ReCog intervention 12 showed 73% of intervention,
and 50% of waitlist participants demonstrated clinically significant improvement on PCI at follow-up. The authors suggested the improvements in the waitlist group might have resulted from increased awareness and improved perceptions of their cognitive functioning because of assessment sessions. These researchers also reported similar improvements on other FACT-Cog-3 subscales for both intervention and waitlist groups, which was seen in the current study on both PCA and QOL subscales.
The interaction on the IADL subscale assessing prospective memory failures was significant. In general terms, it is believed that when people refer to "poor memory" they are referring to prospective Descriptive statistics and effect sizes for neuropsychological tests 
| Strengths and limitations
Strengths in the study include that it is the first known RCT to evaluate 
| Clinical implications
The Web-based cognitive rehabilitation program eReCog shows some promise for improving subjective cognitive functioning and possibly objective cognitive functioning in female adult cancer survivors. Many improvements were found in the waitlist group also, but effect sizes tended to be larger for intervention than waitlist. Development of online cognitive remediation interventions has the potential to provide accessible supportive care to alleviate cognitive symptoms in cancer survivors, particularly those living in smaller communities or with limited mobility.
